Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea · Delayed Price · Currency is KRW 46,350
+3,700 (8.68%)
At close: Nov 26, 2025
Hanall Biopharma Market Cap
Hanall Biopharma has a market cap or net worth of 2.35 trillion as of November 26, 2025. Its market cap has increased by 3.55% in one year.
Market Cap
2.35T
Enterprise Value
2.34T
Revenue
154.05B
Ranking
n/a
PE Ratio
1,018.25
Stock Price
46,350.00
Market Cap Chart
Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 2.35T, an increase of 8,845.05%. That is a compound annual growth rate of 16.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 2.35T | 20.03% |
| Dec 30, 2024 | 1.96T | -12.72% |
| Dec 28, 2023 | 2.25T | 148.89% |
| Dec 29, 2022 | 902.29B | -16.29% |
| Dec 30, 2021 | 1.08T | -43.84% |
| Dec 30, 2020 | 1.92T | 3.31% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 41.00T |
| ALTEOGEN | 28.93T |
| SK Biopharmaceuticals | 9.91T |
| ABL Bio | 9.86T |
| Yuhan | 8.73T |
| Peptron | 8.60T |
| LigaChem Biosciences | 6.49T |